Tangram Therapeutics, formerly e-therapeutics, has relaunched with a sharpened focus on RNA interference and unveiled LLIBRA OS, a next-generation...

RetinalGenix Technologies and RGEN Inc. have formed a strategic partnership to integrate high-resolution retinal imaging with CLIA-certified DNA genotyping,...

Hinge Bio has signed a collaboration and license agreement with Kyorin Pharmaceutical for HB2198, a multispecific antibody targeting CD19...

Nanobiotix reported a step-change half year marked by clinical expansion with JNJ-1900 (NBTXR3), regulatory harmonization in Europe, and a...

Novartis has secured FDA approval for Rhapsido (remibrutinib), an oral Bruton’s tyrosine kinase inhibitor indicated for adults with chronic...

Revolution Medicines has created a chief development officer role and named Alan Sandler, M.D., to the post, while simultaneously...

Connect Biopharma presented new post-hoc analyses at ERS 2025 showing that rademikibart, its investigational anti–IL-4Rα antibody, delivered rapid and...

Novartis will launch a US direct-to-patient platform on November 1, 2025, offering select units of Cosentyx at a 55%...

Cosmos Health has outlined a sweeping restructuring and growth plan anchored by an up to $300 million financing facility...

Neura Health has raised $11.4 million in Series A financing, led by the American Heart Association’s Go Red for...